Adaptive Biotechnologies (ADPT) Profit After Tax Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Profit After Tax Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 8.53% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -1.85% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -4.58% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 13.70% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 6.28% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 10.28% |
| 10 | Adaptive Biotechnologies | 3.78 Bn | 3.56 Bn | 52.17 Mn | 29.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.74% |
| Dec 31, 2025 | 30.27% |
| Sep 30, 2025 | 30.27% |
| Jun 30, 2025 | 21.07% |
| Mar 31, 2025 | 21.95% |
| Dec 31, 2024 | 18.13% |
| Sep 30, 2024 | 16.96% |
| Jun 30, 2024 | 6.20% |
| Mar 31, 2024 | -5.36% |
| Dec 31, 2023 | -15.93% |
| Sep 30, 2023 | -11.08% |
| Jun 30, 2023 | -12.55% |
| Mar 31, 2023 | -22.48% |
| Dec 31, 2022 | -24.91% |
| Sep 30, 2022 | -48.10% |
| Jun 30, 2022 | -49.27% |
| Mar 31, 2022 | -50.55% |
| Dec 31, 2021 | -66.69% |
| Sep 30, 2021 | -88.99% |
| Jun 30, 2021 | -64.88% |